China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals (SXTC) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, though absence of recent events does not indicate absence of risk—the company's financing history and shareholder dilution patterns require deeper analysis. Our real-time detection pipeline captures acute corporate events, but structural vulnerabilities in capital structure and historical filing patterns often signal months in advance. The full $49 Report extends the lookback to 12 months, calculates dilution risk scores, maps the complete financing timeline, and flags AI-detected anomalies in SEC submissions and officer behavior. The full $49 Report adds dilution quantification, 12-month 8-K context, financing trajectory analysis, and AI risk signals.